A Rare Cause of Precocious Puberty - Testotoxicosis

Authors

  • Shi Hui Saw Paediatric Endocrine Unit, Paediatric Department, Hospital Tunku Azizah, Jalan Raja Muda Aziz, Kampung Baru, 50300 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur.
  • Arini Nuran Md Idris Paediatric Endocrine Unit, Paediatric Department, Hospital Tunku Azizah, Jalan Raja Muda Aziz, Kampung Baru, 50300 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
  • Poi-Giok Lim Paediatric Endocrine Unit, Paediatric Department, Hospital Tunku Azizah, Jalan Raja Muda Aziz, Kampung Baru, 50300 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur.

DOI:

https://doi.org/10.51407/mjpch.v30i3.313

Keywords:

Testotoxicosis, familial male-limited precocious puberty, bone age, aromatase inhibitor

Abstract

Background: Testotoxicosis, also known as familial male-limited precocious puberty (FMPP), is a rare cause of gonadotropin-independent precocious puberty in boys due to an activating mutation in the luteinizing hormone (LH))/choriogonadotropin receptor (LHCGR) gene. Case report: A 3-year 2-month-old boy presented with acne, pubic hair, phallic growth, height accelerations, and aggressiveness. At physical examination, his height was 106cm (+2.36 SDS) and weight was 16kg (+0.77 SDS). He had Tanner stage 2 pubic hair, stretched penile length was 6 cm (>2 SDS), and both testicular volumes were 5mls. Bone age was advanced at 7 years old. Testosterone level was high at 17nmol/L and the gonadotropin-releasing hormone (GnRH) stimulation test was suggestive of peripheral precocious puberty. Whole exome sequencing identified a heterozygous pathogenic variant c.1691A>G (p.Asp564Gly) in the LHCGR gene which supports the diagnosis of testotoxicosis. The child was started on both aromatase inhibitor, anastrozole, and anti-androgen, spironolactone. At 6 months of treatment, there was a halt in pubertal progression with reduced height velocity from 9cm/year to 6cm/year. Conclusion: Without intervention, the patient will have rapid progressive skeletal maturation and virilization which will result in compromised final adult height and psychosocial distress.

Downloads

Download data is not yet available.

References

[1] Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993;365(6447):652–654 DOI: https://doi.org/10.1038/365652a0

[2] Gurnurkar S, DiLillo E, Carakushansky M. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation. J Clin Res Pediatr Endocrinol. 2021 Jun 2;13(2):239-244. doi: 10.4274/jcrpe.galenos.2020.2020.0067. Epub 2020 Aug 6. PMID: 32757547; PMCID: PMC8186329. DOI: https://doi.org/10.4274/jcrpe.galenos.2020.2020.0067

[3] Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB Jr. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty. J Pediatr. 2017 Nov;190:229-235. doi: 10.1016/j.jpeds.2017.07.047. PMID: 29144249; PMCID: PMC5726420. DOI: https://doi.org/10.1016/j.jpeds.2017.07.047

[4] A. Daussac, P. Barat, N. Servant, M. Yacoub, S. Missonier, F Lavran, L. Gaspari, C. Sultan & F. Paris (2019): Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation, Endocrine Research, DOI: 10.1080/07435800.2019.1645163 DOI: https://doi.org/10.1080/07435800.2019.1645163

[5] Lane LC, Flowers J, Johnstone H, Cheetham T. Adult height in patients with familial male-limited precocious puberty and the role of an aromatase inhibitor in patient management. J Pediatr Endocrinol Metab. 2018 Apr 25;31(5):551-560. doi: 10.1515/jpem-2017-0363. PMID: 29654692. DOI: https://doi.org/10.1515/jpem-2017-0363

[6] Bertelloni S, Baroncelli GI, Lala R, Cappa M, Matarazzo P, De Sanctis C, Saggese G. Long-term outcome of male-limited gonadotropin-independent precocious puberty. Horm Res. 1997;48(5):235-9. doi: 10.1159/000185521. PMID: 9362394. DOI: https://doi.org/10.1159/000185521

[7] Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Amrhein J, De Luca F, O'Brien S, Armstrong J, Melezinkova H. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab. 2010 Oct;23(10):999-1009. doi: 10.1515/jpem.2010.161. PMID: 21158211 DOI: https://doi.org/10.1515/jpem.2010.161

[8] Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, Lewis KA. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010 Sep;126(3):e728-33. doi: 10.1542/peds.2010-0596. Epub 2010 Aug 16. PMID: 20713483; PMCID: PMC4096839. DOI: https://doi.org/10.1542/peds.2010-0596

[9] Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr. 2006 Sep;149(3):416-20. doi: 10.1016/j.jpeds.2006.04.027. PMID: 16939760. DOI: https://doi.org/10.1016/j.jpeds.2006.04.027

[10] Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. J Bone Miner Res. 2010 Jul;25(7):1536-43. doi: 10.1002/jbmr.56. PMID: 20200972. DOI: https://doi.org/10.1002/jbmr.56

[11] Yuan X, Chen R, Zhang Y, Yang X, Lin X. Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty. Front Endocrinol (Lausanne). 2022 Jul 14;13:906852. doi: 10.3389/fendo.2022.906852. PMID: 35909557; PMCID: PMC9329579. DOI: https://doi.org/10.3389/fendo.2022.906852

[12] Kooij CD, Mavinkurve-Groothuis AMC, Kremer Hovinga ICL, Looijenga LHJ, Rinne T, Giltay JC, de Kort LMO, Klijn AJ, de Krijger RR, Verrijn Stuart AA. Familial Male-limited Precocious Puberty (FMPP) and Testicular Germ Cell Tumors. J Clin Endocrinol Metab. 2022 Nov 23;107(11):3035-3044. doi: 10.1210/clinem/dgac516. PMID: 36071555; PMCID: PMC9681611. DOI: https://doi.org/10.1210/clinem/dgac516

Downloads

Published

2024-12-03

How to Cite

Saw, S. H., Md Idris, A. N., & Lim, P.-G. (2024). A Rare Cause of Precocious Puberty - Testotoxicosis . Malaysian Journal of Paediatrics and Child Health, 30(3), 1–6. https://doi.org/10.51407/mjpch.v30i3.313

Issue

Section

Case Report